| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 283 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 283 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 3.817 | 99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -3.534 | -99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -3.542 | -99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Avamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.733 | 5.590 | 5.496 | 5.395 | 5.290 | 5.190 | 5.075 | 5.091 | 5.075 | 5.047 |
| Current Assets | 14 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 14 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 |
| Shareholders Funds | -63.930 | -63.378 | -62.305 | -61.162 | -59.977 | -58.840 | -57.535 | -57.714 | -57.539 | -57.217 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 69.678 | 68.975 | 67.808 | 66.563 | 65.274 | 64.037 | 62.617 | 62.811 | 62.620 | 62.270 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Avamed S.r.l.